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Escherichia coli O157:H7, a zoonotic human pathogen for which domestic cattle are a reservoir host,
produces a Shiga toxin(s) (Stx) encoded by bacteriophages. Chromosomal insertion sites of these bacterio-
phages define three principal genotypes (clusters 1 to 3) among clinical isolates of E. coli O157:H7. Stx-
encoding bacteriophage insertion site genotypes of 282 clinical and 80 bovine isolates were evaluated. A total
of 268 (95.0%) of the clinical isolates, but only 41 (51.3%) of the bovine isolates, belonged to cluster 1, 2, or 3
(P < 0.001). Thirteen additional genotypes were identified in isolates from both cattle and humans (four
genotypes), from only cattle (seven genotypes), or from only humans (two genotypes). Two other markers
previously associated with isolates from cattle or with clinical isolates showed similar associations with
genotype groups within bovine isolates; the tir allele sp-1 and the Q933W allele were under- and overrepresented,
respectively, among cluster 1 to 3 genotypes. Stx-encoding bacteriophage insertion site typing demonstrated
that there is broad genetic diversity of E. coli O157:H7 in the bovine reservoir and that numerous genotypes
are significantly underrepresented among clinical isolates, consistent with the possibility that there is reduced
virulence or transmissibility to humans of some bovine E. coli O157:H7 genotypes.
Escherichia coli O157:H7 is an important food- and water-
borne zoonotic pathogen that expresses two cardinal virulence
factors: the ability to produce one or more Shiga toxins (Stx)
encoded by genes located in lambdoid bacteriophages (8, 33)
and the ability to attach intimately to epithelial cells via ex-
pression of a pathogenicity island termed the locus of entero-
cyte effacement (LEE) (31).
Feng et al. described a plausible series of evolutionary
events leading to the evolution of the dominant non-sorbi-
tol-fermenting, -glucuronidase-negative E. coli O157:H7
clade from a nontoxigenic progenitor, E. coli O55:H7 (5).
Shaikh and Tarr (27) assayed clinical isolates of this domi-
nant E. coli O157:H7 clade for the Stx-encoding bacterio-
phage insertion sites defined in the strains that have been
sequenced (7, 24). Three principal groups of isolates sharing
Stx bacteriophage insertion site genotypes were identified:
isolates with an Stx2-encoding bacteriophage inserted at a
location other than wrbA and with yehV occupied by a cen-
trally truncated bacteriophage (cluster 1), isolates with an
Stx2-encoding bacteriophage inserted into wrbA and with
yehV occupied by a truncated bacteriophage as in cluster 1
(cluster 2), and isolates with a complete Stx1-encoding bac-
teriophage inserted into yehV and with an Stx2-encoding
bacteriophage inserted into wrbA (cluster 3).
Association of the genetic diversity within the sorbitol-
negative, -glucuronidase-negative E. coli O157:H7 clade
with prophage insertions has been demonstrated previously.
Kim et al. (14) identified two major lineages within this
clade using octamer-based genomic scanning and also found
prophage sequences in some of the polymorphic bands de-
tected by this method. Ohnishi et al. (22) used whole-
genome PCR scanning and concluded that variation among
bacteriophages is a major factor in generating genomic di-
versity within the O157 lineage. Comparative genomic mi-
croarray hybridization demonstrated that prophage or prophage-
related elements accounted for 85% of the variably present
genes in 12 E. coli isolates representing the O157:H7 evolutionary
lineage (34).
Cattle are a major reservoir of E. coli O157:H7, but colo-
nized animals typically exhibit no disease (6). E. coli O157 is
ubiquitous on cattle farms, and the prevalence of cattle shed-
ding this agent frequently is greater than 10% and can ap-
proach 100% (6). The high prevalence of this agent in cattle
contrasts with the comparative rarity of human infection, de-
spite the reportedly low infectious dose (13, 28, 32).
In this study, we characterized the bacteriophage inser-
tion site genotypes of E. coli O157:H7 isolates from cattle
and from humans and found increased genotype diversity
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among bovine isolates and differential representation of ge-
notypes in these host species.
MATERIALS AND METHODS
Bacterial isolates. Eighty E. coli O157:H7 isolates from cattle were randomly
selected from isolates obtained during various Washington State University
surveys between 1991 and 2004 (Table 1). All studies involving animals were
performed under appropriate animal use guidelines with the approval of the
WSU Institutional Animal Care and Use Committee. The random selection was
stratified so that the group included 20 isolates each from four time periods
(1991 to 1994, 1995 and 1996, 1997 to 2000, and 2001 to 2004), limited to single
isolates from individual farms within each period. An additional set of stx1-
negative, stx2-positive bovine isolates was selected to search for an unusual
genotype, as described below.
Clinical E. coli O157:H7 isolates were obtained from five different studies
(Table 1). Study 1 isolates were obtained from Seattle area patients of all ages
(30). Study 2 isolates originated from children up to 10 years old in a four-state
region (4, 12). Study 3 isolates originated from patients up to 21 years old at the
Seattle Children’s Hospital and Regional Medical Center (CHRMC) (16). Study
4 isolates originated from Montana patients of all ages (12). Study 5 isolates
originated from CHRMC patients up to 21 years old. Only a single isolate from
each recognized cluster of infections was included in this analysis to maximize the
independence of the isolates. Outcomes (hemolytic-uremic syndrome [HUS]
versus no HUS) were available for 248 patients, 51 of whom developed HUS.
Each of these studies was performed in accordance with the human experimen-
tation guidelines of the U.S. Department of Health and Human Services and
with approval from one or more of the Institutional Review Boards of the
CHRMC, the University of Washington, and Washington University.
The control strains used in this study included E. coli O157:H7 strains 87-14
(cluster 1) and 86-24 (cluster 2) (30), and EDL933 ( ATCC 43895; ATCC,
Manassas, VA) (cluster 3), and E. coli K-12 strain INVF (Invitrogen Corp.,
Carlsbad, CA).
Bovine isolate characterization. Bovine isolates were tested for sorbitol fer-
mentation and -glucuronidase expression as described previously (18). O157
antigen expression was detected by latex agglutination (E. coli PRO O157;
PL.070HD; Hardy Diagnostics, Santa Maria, CA). Multiplex PCR was used to
detect eae, stx1, and stx2 in all bovine isolates (23).
For multilocus sequence typing, seven loci (aspC, clpX, fadD, icdA, lysP, mdh,
and uidA) were sequenced and allele profiles were used to assign a sequence type
TABLE 1. Year and state or province of origin for isolates used in this study
Year of
isolation Host Study(ies)
No. of isolates obtained at the following locations:
WA ID OR MT WY MO KS NE TX PA AB Total
1984 Human 1 1 0 0 0 0 0 0 0 0 0 0 1
1986 Human 1 3 0 0 0 0 0 0 0 0 0 0 3
1987 Human 1 4 0 0 0 0 0 0 0 0 0 0 4
1991 Bovine Va 10 0 0 0 0 0 0 0 0 0 0 10
1993 Bovine V 5 1 0 0 0 0 0 0 0 0 1 7
1994 Bovine V 2 0 1 0 0 0 0 0 0 0 0 3
1995 Bovine V 5 3 3 0 0 0 0 1 0 0 0 12
1996 Bovine V 4 0 0 0 0 0 0 1 1 1 1 8
1997 Human 2 18 0 0 0 0 0 0 0 0 0 0 18
Bovine V 1 1 0 0 0 0 0 0 0 0 0 2
1998 Human 2, 3, 4 16 1 1 6 0 0 0 0 0 0 0 24
Bovine V 2 0 0 0 0 0 1 0 0 0 1 4
1999 Human 2, 3, 4 38 1 1 25 1 0 0 0 0 0 0 66
Bovine V 6 0 0 0 0 0 0 0 0 0 0 6
2000 Human 2, 3 42 1 1 0 0 0 0 0 0 0 0 44
Bovine V 7 0 0 0 0 0 0 0 0 0 0 7
2001 Human 3 27 1 1 0 0 0 0 0 0 0 0 29
Bovine V 8 1 0 0 0 0 0 0 0 0 1 10
2002 Human 2, 5 16 0 2 0 0 0 0 0 0 0 0 18
Bovine V 1 1 0 0 0 0 0 0 0 0 0 2
2003 Human 2, 5 18 0 2 0 0 3 0 0 0 0 0 23
2004 Human 2, 5 29 7 1 0 0 3 0 0 0 0 0 40
Bovine V 0 0 0 0 0 0 0 0 0 0 9 9
2005 Human 2, 5 5 0 0 0 0 7 0 0 0 0 0 12
Total Human All 217 11 9 31 1 13 0 0 0 0 0 282
Bovine V 51 7 4 0 0 0 1 2 1 1 13 80
a V indicates that isolates were obtained in various cattle studies at Washington State University.
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(ST) to each bovine isolate (11, 25) using protocols available on the STEC
Center website (http://www.shigatox.net/mlst).
Stx1 and Stx2 expression was detected by a gold-labeled immunosorbent assay
(DuoPath Verotoxins, EMD Inc., Darmstadt, Germany) with broth culture su-
pernatants, using carbadox (25 ng/ml; Sigma-Aldrich, St. Louis, MO) to induce
Stx production. The verocytotoxicity of bovine isolates was confirmed by direct
microscopic observation of Vero cell monolayers in 96-well plates 24 and 48 h
after addition of 1:10 dilutions of filter-sterilized (0.45 m; Millipore, Billerica,
MA) overnight carbadox-induced broth culture supernatants in minimal essen-
tial medium (MEM) containing 5% fetal bovine serum (FBS). Total Stx produc-
tion by bovine isolates was quantified by an enzyme immunoassay (Premier
EHEC assay; Meridian Bioscience, Cincinnati, OH) with overnight carbadox-
induced broth culture supernatants. E. coli DH5 (stx negative) was used as a
negative control and E. coli O157:H7 strain EDL933 was used as a positive
control for these Stx assays.
Stx-encoding bacteriophage insertion sites. Study isolates were interrogated
for Stx genes, for Stx-encoding bacteriophage-chromosome junctions, and for
intact bacteriophage insertion site regions by PCR (27) (Table 2). The presence
of intact chromosomal insertion site regions (yehV and wrbA) was confirmed in
all isolates with negative reactions for Stx-encoding bacteriophage-chromosome
junctions. Selected bovine isolates with variant patterns of bacteriophage inser-
tion in yehV (right junction negative and left junction positive) were subjected to
amplification of a longer segment of the variant right junction by long PCR
(Platinum Taq High Fidelity DNA polymerase [Invitrogen]; 35 cycles of 94°C for
30 s, 58°C for 30 s, and 68°C for 5 min). Cloning (TA cloning kit; Invitrogen) and
partial DNA sequencing (Amplicon Express, Pullman, WA) of the resulting
product allowed us to design a new reverse primer (E2) (Table 2) specific for the
variant right yehV-bacteriophage junction. An additional group of 128 stx2-pos-
itive, stx1-negative bovine isolates was subjected to PCR analysis of Stx-encoding
bacteriophage insertion sites to screen for the cluster 2 genotype, which occurs in
a minority of human clinical isolates (27) and was absent from the initial group
of 80 randomly selected bovine isolates.
Detection of additional genetic markers in bovine isolates. A multiplex PCR
was designed to specifically detect the Stx2c-encoding bacteriophage (29). In the
multiplex reaction we used 0.5 l of 10 M primers stx2c-F, stx2c-R, O-F, O-R,
Q-F, and Q-R (Table 2) to amplify stx2c and the O and Q genes of the Stx2c-
encoding bacteriophage, as well as primers to amplify the malate dehydrogenase
(mdh) gene as a positive PCR control. Each 25-l reaction mixture contained 2.5
l of 10 buffer II (Applied Biosystems, Foster City, CA), 2.5 l of 2 mM
deoxynucleoside triphosphates, 2.0 l of 25 mM MgCl2, the six Stx2c-encoding
bacteriophage-specific primers listed above, 1 l of each of the two mdh primers,
0.3 l of 1.5 U AmpliTaq Gold (Applied Biosystems), 1 l of a 25-ng/l genomic
DNA template, and 11.7 l of double-distilled H2O. The amplification cycle
included an initial denaturation step (94°C for 10 min), 35 amplification cycles
TABLE 2. Nucleotide sequences of primers used for PCR analyses in this study
Primer Sequence (5–3) Target Reference(s)
A AAGTGGCGTTGCTTTGTGAT yehV insertion site region 27
B AACAGATGTGTGGTGAGTGTCTG
A AAGTGGCGTTGCTTTGTGAT Bacteriophage-yehV right junction 27
E GATGCACAATAGGCACTACGC
F CACCGGAAGGACAATTCATC Bacteriophage-yehV left junction 27
B AACAGATGTGTGGTGAGTGTCTG
C AGGAAGGTACGCATTTGACC wrbA insertion site region 27
D CGAATCGCTACGGAATAGAGA
C AGGAAGGTACGCATTTGACC Bacteriophage-wrbA right junction 27
G ATCGTTCGCAAGAATCACAA
H CCGACCTTTGTACGGATGTAA Bacteriophage-wrbA left junction 27
D CGAATCGCTACGGAATAGAGA
A AAGTGGCGTTGCTTTGTGAT Variant bacteriophage-yehV right junction 27; this study
E2 CAGGGAATCAATCGCAGTTT
595 CCGAAGAAAAACCCAGTAACAG stx2-antiterminator Q gene junction 33, 17
Q933 CGGAGGGGATTGTTGAAGGC
TirF TCATGTTCAGCCGTTTATCG tir This study
TirR AAGCTCAAGAGTTGCCCATC
A AAGTGGCGTTGCTTTGTGAT Bacteriophage-yehV right junction (	8 kb) 27; this study
R1 GCAGATGATGAGCGTGATTG
FimH460F CTTATGGCGGCGTGTTATCTA FimH mannose-binding pocket flanking N135K Shaikh et al.,
submittedFimH460R GCCAGTAGGCACTACCACATC
stx2c-F919 CTGAACAGAAAGTCACAGTYTTTA stx2c-specific region This study
stx2c-R1100 GGCCACTTTTACTGTGAATGTATC
O-F163 ATGCGCAAGACATACGGATTC Stx2c bacteriophage O gene This study
O-R695 TGCACAAACGCCCTGACATA
Q-F69 GGGCGCATGGGTTTATTCA Stx2c bacteriophage Q gene This study
Q-R389 ACTTCCCGTCGGCAGGTTG
mdh-F41 AGGCGCTTGCACTACTGTTA mdh This study
mdh-R875 AGCGCGTTCTGTTCAAATG
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(92°C for 1 min, 55°C for 1 min, and 72°C for 30 s), and a final extension step
(72°C for 5 min). PCR products were visualized on ethidium bromide-stained
1.5% agarose gels by illumination with UV light. The presence of the Stx2c-
encoding bacteriophage was inferred in isolates that produced the following four
amplicons: mdh (835 bp), stx2c (182 bp), O (533 bp), and Q (321 bp).
The sp-1 polymorphism (D78E) in tir was detected by a real-time PCR
TaqMan assay (J. L. Bono, J. E. Keen, M. L. Clawson, L. M. Durso, M. P.
Heaton, and W. W. Laegreid, Abstr. 104th Gen. Meet. Am. Soc. Microbiol.,
abstr. C-388, 2005) or by sequencing a tir PCR product (Table 2). The junction
between the antiterminator Q of bacteriophage 933W and stx2 was detected by
PCR (Table 2) (17). An N135K polymorphism in fimH was detected by sequenc-
ing PCR products (Table 2) (N. Shaikh, N. J. Holt, J. R. Johnson, and P. I. Tarr,
submitted for publication).
Adherence to MDBK cells was quantified as described by Monteville et al.
(21). A three-color immunofluorescence analysis of the E. coli O157:H7
interaction with MDBK cells was performed using strains transformed with a
green fluorescent protein (GFP) gene-containing plasmid, pMEK91 (20).
MDBK cells (5  104 cells/well) were cultured on glass coverslips for 18 h at
37°C in a humidified incubator containing 5% CO2. The cells were infected
with a 10:l dilution of a log-phase culture of GFP-transformed E. coli in 1 ml
of Tris (10 mM, pH 7.4)-buffered minimal essential medium supplemented
with 1% (vol/vol) FBS. Infected cells were incubated (3 h), rinsed with MEM,
and reincubated in MEM containing FBS (4 h). Cells were washed three
times with phosphate-buffered saline, fixed (2% paraformaldehyde), and per-
meabilized (0.1% Triton X-100). Actin was stained using tetramethylrhoda-
mine isothiocyanate-labeled phalloidin (0.2 g/ml; Sigma, St. Louis, MO).
Coverslips were mounted using Vectashield (Vector Laboratories Inc., Bur-
lingame, CA) with 4,6-diamidino-2-phenylindole (DAPI) and were visual-
ized using epifluorescence (Nikon Eclipse TE2000). Images were captured
with the MetaMorph version 5 imaging software and were formatted using
Adobe Photoshop 3.0.4.
Statistical analysis. The distribution of Stx-encoding bacteriophage inser-
tion site genotypes in human and cattle isolates and the associations between
the fimH, tir sp-1, Q933, and stx2c markers and the Stx-encoding bacteriophage
insertion site genotypes in isolates from cattle were evaluated by 
2 tests
(SigmaStat; SPSS, Inc., Chicago, IL). Differences in Stx production and
differences in adherence of selected E. coli O157:H7 isolates to MDBK cells
were evaluated by one-way analysis of variance (SigmaStat), and where dif-
ferences were detected, pairwise multiple comparisons were performed using
the Tukey test.
RESULTS
Identification and characterization of bovine isolates. All
bovine isolates expressed the O157 antigen, were positive
for eae and tir, and fermented lactose but not sorbitol; none
expressed -glucuronidase. All but one isolate were positive
for stx1 or stx2 or both (Table 3). Multilocus sequence typing
assigned 79 of the 80 isolates to ST-66, the most common ST
of the -glucuronidase-negative, non-sorbitol-fermenting
clade of E. coli O157:H7 in the United States, consistent
with their membership in this clade. The one remaining
isolate was assigned to ST-350, which differs from ST-66 by
a single nucleotide in fadD.
Stx-encoding bacteriophage insertion sites. Clinical isolates
of E. coli O157:H7 (Table 1) were analyzed to determine their
Stx-encoding bacteriophage insertion genotypes. Clusters 1 to
3, as defined previously, accounted for 268 (95%) of the 282
isolates (Table 3). Six additional, less frequent genotypes were
identified among the clinical isolates. Genotype 4 (n  5;
1.8%) was characterized by the presence of stx2, the absence of
stx1, an intact yehV site, and a bacteriophage-occupied wrbA
site; genotype 5 (n  4; 1.4%) was characterized by the pres-
ence of stx2, the absence of stx1, amplification of the left but not
the right yehV-bacteriophage junction (designated yehV-Vari-
ant-R), and an intact wrbA site; genotype 6 (n  2; 0.7%) was
TABLE 3. Genotyping data, isolate sources, and further characterization of bovine isolates of E. coli O157:H7
Genotypea
Genotyping data No. (%) of isolates from: Additional markers (bovine isolates only)
stx b yehV c wrbAd Cattle Clinical sources fim(N135K)e Q933W-stx2
f stx2c
g tir sp-1 (D78E)h
Cluster 1 2 Occupied Intact 8 (10) 85 (30.1) N (5) 7 1 D (7), E (1)
Cluster 2 2 Occupied Occupied 0 (0) 7 (2.5)
Cluster 3 1  2 Occupied Occupied 33 (41.3) 176 (62.4) K (5) 33 1 D (32), E (1)
Genotype 4 2 Intact Occupied 1 (1.3) 5 (1.8) K (1) 1 0 D (1)
Genotype 5 2 Variant-R Intact 9 (11.3) 4 (1.4) N (5) 1 8 D (3), E (6)
Genotype 6 1  2 Variant-R Intact 15 (18.8) 2 (0.7) N (5) 10 13 D (10), E (5)
Genotype 7 1  2 Variant-R Occupied 5 (6.3) 1 (0.3) K (5) 5 0 D (5)
Genotype 8 1 Occupied Intact 0 (0) 1 (0.3)
Genotype 9 None Intact Intact 0 (0) 1 (0.3)
Genotype 10 None Occupied Intact 1 (1.3) 0 (0) N (1) 0 0 D (1)
Genotype 11 2 Intact Intact 2 (2.5) 0 (0) N (2) 1 0 D (1)
Genotype 12 2 Variant-R Occupied 1 (1.3) 0 (0) K (1) 1 0 D (1)
Genotype 13 1 Variant-R Intact 1 (1.3) 0 (0) K (1) 1 0 D (1)
Genotype 14 1 Variant-R Occupied 2 (2.5) 0 (0) K (2) 0 0 D (2)
Genotype 15 1  2 Intact Intact 1 (1.3) 0 (0) N (1) 1 1 D (1)
Genotype 16 1  2 Occupied Intact 1 (1.3) 0 (0) N (1) 1 0 D (1)
a Stx-encoding bacteriophage insertion site genotypes. The cluster genotypes are genotypes identified in multiple clinical isolates in a previous study (27). The
genotypes are based on patterns of Stx genes and Stx-encoding bacteriophage insertion sites described in this study.
b PCR gene detection of stx1 (1) and/or stx2 (2) (23).
c “Occupied” indicates bilateral detection of the yehV–Stx-1-encoding bacteriophage junctions (with the A-E and B-F primer pairs, respectively Table 2). “Intact”
indicates detection of neither junction. “Variant-R” indicates that the left junction between the bacteriophage and the chromosome was detected but the right junction
was not detected. Most yehV-Variant-R isolates share a different right junction sequence, as described in Results.
d “Occupied” indicates bilateral detection of the wrbA–Stx-2-encoding bacteriophage junctions (with the C-G and D-H primer pairs Table 2). “Intact” indicates
detection of neither junction.
e N and K indicate the status of the N135K polymorphism (N. Shaikh et al., submitted for publication) in the FimH mannose-binding pocket in bovine isolates. All
isolates were tested for genotype groups containing less than six isolates; five isolates were randomly selected for testing from each larger genotype group.
f The numbers indicate the numbers of bovine isolates that were PCR positive for the Q-stx2 junction of phage 933W.
g The numbers indicate the numbers of bovine isolates positive as determined by multiplex PCR for the Stx2c-encoding bacteriophage.
h The numbers in parentheses indicate the numbers of bovine isolates in which the alleles of the D78E (T238A) single-nucleotide polymorphism in tir were detected.
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characterized by the presence of both stx1 and stx2, yehV-Vari-
ant-R, and an intact wrbA site; genotype 7 (n  1; 0.4%) was
characterized by the presence of both stx1 and stx2, yehV-Vari-
ant-R, and a bacteriophage-occupied wrbA site; genotype 8
(n  1; 0.4%) was characterized by the presence of stx1, the
absence of stx2, a bacteriophage-occupied yehV site, and an
intact wrbA site; and genotype 9 (n  1; 0.4%) was character-
ized by the absence of stx1 and stx2 and intact yehV and wrbA
sites (Table 3).
In contrast, the cluster 1 to 3 genotypes were found much
less frequently among the bovine isolates (n  41; 51.3%)
(Table 3). The distribution of clusters 1 to 3 and “other”
genotypes (all remaining genotypes) differed significantly in
the clinical and bovine isolates (
2  98.2, 3 df, P  0.001;
including no more than a single isolate per farm with the same
genotype). One bovine isolate had genotype 4. Genotypes 5
(n  9; 11.3%), 6 (n  15; 18.8%), and 7 (n  5; 6.3%) were
each overrepresented among cattle isolates compared to the
clinical isolates (in each case, 
2  9.8, 1 df, and P 0.01). The
remaining nine bovine isolates had seven additional Stx-encod-
ing bacteriophage insertion site genotypes that were not de-
tected among the clinical isolates. These genotypes, designated
genotypes 10 to 16, each were found in only one or two strains;
the specific results are shown in Table 3. Because the cluster 2
genotype was not detected among the randomly chosen set of
80 bovine isolates, 124 additional bovine isolates previously
determined to have the appropriate stx1-negative, stx2-positive
profile were screened for the cluster 2 genotype, and four of
these strains (3.2%) had cluster 2 genotypes, confirming the
presence of cluster 2 isolates in the bovine reservoir, albeit at
a low frequency.
The yehV-Variant-R bacteriophage junction was character-
ized further in view of the relatively high frequency of geno-
types with this reaction, particularly among bovine isolates.
Considering the possibility that the region complementary to
primer E (Table 2) had been deleted or disrupted, we at-
tempted to amplify a larger segment of the right bacterio-
phage-yehV junction using yehV primer A (Table 2) paired with
a primer designed to amplify approximately 7.5 kb of the right
yehV-stx1 bacteriophage junction. This long PCR amplified a
7.5-kb product from the template of the positive control strain
(EDL933; cluster 3); in contrast, it amplified 8-kb products
from the templates of two yehV-Variant-R isolates (genotype
groups 5 and 6). This PCR product was cloned, and a partial 5
sequence was obtained. The initial 362 bp of this sequence was
100% identical to the yehV-stx1 prophage junction of entero-
hemorrhagic E. coli Sakai, but the next 738 bp was most similar
(96% identity) to E. coli O157:H7 strain Sakai genes
ECs2153 and ECs2154, located adjacent to another cryptic
prophage in the Sakai genome (GenBank accession no.
EF081034). This sequence was used to design a new reverse
primer, E2 (Table 1), which, combined with yehV forward
primer A, specifically amplified the yehV-Variant-R junction
sequence from 23 of 30 (76.7%) bovine yehV-Variant-R
isolates. All bovine isolates in which yehV sites were intact
(n  13) or occupied (n  10) were negative as determined
by this PCR.
Stx and LEE effector expression by bovine E. coli O157:H7
isolates. All bovine isolates in which one or more stx genes
were detected produced verocytotoxigenic culture superna-
tants; the single stx-negative isolate (genotype 10) was non-
toxic. The Stx expression detected by the gold-labeled immu-
nosorbent assay agreed exactly with the stx detected by PCR
for 76 of the 80 bovine isolates. The four exceptions included
one genotype 5 isolate and two genotype 6 isolates that did not
express detectable Stx2 and one genotype 16 isolate that did
not express detectable Stx1. Five randomly selected bovine
isolates from genotype groups with six or more isolates and all
isolates from genotype groups with fewer members were eval-
uated for Stx production by an enzyme immunoassay (Table 4);
significant differences in Stx production in different genotype
groups were detected (P  0.019, as determined by one-way
analysis of variance). The Tukey multiple-comparison proce-
dure indicated that the cluster 3 isolates tested produced sig-
nificantly more Stx than the genotype 5 isolates tested pro-
duced; no other statistically significant differences in Stx
production in different genotype groups were identified.
Randomly selected bovine isolates with the cluster 1 or
cluster 3 genotype or genotype 5, 6, or 7 all exhibited com-
parable quantitative adherence to MDBK cells (Table 4).
Similarly, randomly selected bovine isolates with the cluster
1, cluster 2, or cluster 3 genotype or genotype 5 or 6 all
produced qualitatively similar adherent E. coli O157:H7 mi-
crocolonies and focal actin accumulation on MDBK cells
(Fig. 1).
Geographic and temporal distributions of E. coli O157:H7
genotypes. The bovine isolates originated from 69 different
cattle farms in seven states in the United States and one Ca-
nadian province (Table 1). Neither secular nor geographic
trends were observed in the distribution of Stx-encoding bac-
teriophage insertion site genotypes (data not shown). Twenty-
five of the bovine isolates were obtained from predominantly
beef breeds and 55 were obtained from dairy breeds, and there
were not significant differences in genotype distribution be-
tween the breeds. Eight farms contributed more than one study
isolate. Multiple isolates obtained during different time peri-
TABLE 4. Stx production by and cytoadherence of E. coli O157:H7
genotypes isolated from cattle
Genotype
Stx productiona Cytoadherenceb
No. of
isolates
Mean optical
density (SD)
No. of
isolates
Mean adherence
(SD)
Cluster 1 5 1.61 (0.88) 2 39.7 (31.7)
Cluster 3 5 1.73 (0.93) 2 9.8 (7.7)
Genotype 4 1 1.57 NDc
Genotype 5 5 0.24 (0.27) 3 27.7 (19.6)
Genotype 6 5 0.57 (0.54) 3 55.3 (82.7)
Genotype 7 5 1.53 (1.02) 2 11.3 (6.4)
Genotype 8 1 0.08 ND
Genotype 9 2 1.87 (0.10) ND
Genotype 10 1 1.66 ND
Genotype 11 1 0.18 ND
Genotype 12 2 0.27 (0.04) ND
Genotype 13 1 0.31 ND
Genotype 14 1 1.00 ND
a Stx production as measured by an enzyme immunoassay using overnight
broth cultures of E. coli O157:H7 isolates with bacteriophage induction by
carbadox (25 ng/ml).
b Cytoadherence to MDBK cells. The results are fold increases in the number
of adherent CFU per well compared to the E. coli INVF control strain.
c ND, not determined.
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ods from single farms tended to share Stx-encoding bacterio-
phage insertion site genotypes; six farms contributed isolates
with the same genotype on two (four farms) or three (two
farms) occasions separated by 1 to 8 years. The genotypes
repeatedly isolated from these single farms included cluster 1
(one farm) and 3 (three farms) genotypes and genotypes 5 and
11 (one farm each). Two isolates obtained 2 years apart from
a seventh farm had genotype 6, while a third isolate from that
farm obtained 4 years later was a cluster 3 strain. Finally, two
isolates obtained 2 years apart on the eighth farm had the
cluster 3 genotype and genotype 6.
Human isolates were recovered from patients in six states in
the United States in two time periods, 1984 to 1987 and 1997
to 2005. Neither secular nor geographic trends were observed
in the distribution of the Stx-encoding bacteriophage insertion
site genotypes (data not shown).
Stx2c bacteriophage. The Stx2c-encoding bacteriophage, as
inferred by PCR detection of stx2c and specific O and Q gene
sequences, was detected in 24 of the 80 bovine isolates, includ-
ing cluster 1 and 3 genotype and genotype 5, 6, and 15 isolates
(Table 3). stx2c occurred less frequently among bovine isolates
with cluster 1 and 3 genotypes (2 of 41 isolates) than in bovine
isolates with other genotypes (22 of 39 isolates; 
2  22.9, 1 df,
P 0.001) (Table 3). In the context of human disease, while E.
coli O157:H7 with genes encoding Stx2c is unusual, it may be
associated with more severe illness (12).
fimH mannose binding pocket polymorphism. Representa-
tive bovine isolates (all isolates in genotype groups with less
than five isolates and five randomly chosen isolates each for all
other genotype groups) were examined for the presence of a
single-nucleotide polymorphism in fimH resulting in an N135K
amino acid sequence change in the mature FimH protein.
Fourteen isolates with wrbA occupied by bacteriophage all
carried the K allele, while 20 of 21 isolates with wrbA intact
carried the N allele (
2  27.3, 1 df, P  0.001) (Table 3). The
segment of wrbA amplified by primers C and D (Table 2) in
the single wrbA-intact, K allele-positive isolate was identical to
the segment of the same region in E. coli K-12 wrbA.
Q933W and tir polymorphic markers. The bacteriophage
Q933W-stx2 junction was detected by PCR in 40 of 41 cattle
isolates with the cluster 1 or 3 genotype but in only 21 of 39
isolates having other genotypes (
2  18.7, 1 df, P  0.001).
The T238A (D78E) tir polymorphism designated sp-1 was de-
tected in only 2 of 41 cattle isolates with the cluster 1 or 3
genotype but in 11 of 38 isolates with other genotypes, partic-
ularly genotypes 5 (6 of 9 isolates) and 6 (5 of 15 isolates) (
2 
10.7, 1 df, P  0.001).
DISCUSSION
Our typing system revealed a diversity of Stx-encoding bac-
teriophage insertion site genotypes among E. coli O157:H7
from the bovine reservoir that was considerably broader than
that expected on the basis of analysis of human isolates. Some
of the genotypes detected among isolates from both species
were markedly overrepresented in clinical isolates (clusters 1
and 3) or bovine isolates (genotypes 5 to 7). All genotypes
represented by two or more clinical isolates (cluster 1 to 3
genotypes and genotypes 4 to 6) were identified in isolates
from cattle (although discovery of a bovine cluster 2 strain
FIG. 1. Actin polymerization associated with E. coli O157:H7 microcolonies adhering to MDBK cells: three-color immunofluorescence analysis
of E. coli O157:H7 interaction with MDBK cells. Blue, DAPI staining of nuclear DNA; red, tetramethylrhodamine isothiocyanate-conjugated
phalloidin staining of actin; green, GFP plasmid-transformed E. coli cells. (A) E. coli O157:H7 strain EDL933 (cluster 3; positive control); (B) E.
coli O157:H7 strain 86-24 (cluster 2; positive control); (C) E. coli O157:H7 bovine isolate (cluster 1); (D) E. coli O157:H7 genotype 5 bovine isolate;
(E) E. coli O157:H7 genotype 6 bovine isolate; (F) E. coli K-12 strain InvF (negative control).
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required screening of additional isolates), consistent with the
hypothesis that cattle are the reservoir for E. coli O157:H7
resulting in human disease. Most (10/13) of the genotype
groups identified for the first time in this study had only one or
two members, indicating that identification of additional diver-
sity is likely to occur when more isolates, particularly isolates
from the bovine reservoir, are analyzed.
We considered the possibility that lysogenization and exci-
sion events in the short term, such as during a single human or
animal gastrointestinal passage, could result in changes in the
Stx-encoding bacteriophage insertion site genotypes of E. coli
O157:H7 characterized in this study. However, the available
evidence generally does not support this possibility. First, pre-
vious studies of non-sorbitol-fermenting, -glucuronidase-neg-
ative E. coli O157:H7 suggested that the acquisition of Stx-
encoding phages was a key event in the evolution of this
pathogenic clade from precursor strains and thus predated the
divergence detected on the basis of these genotypes within the
clade (5, 34). Consistent with this view, we demonstrated here
the correlation between wrbA site occupancy and fimH (a non-
prophage gene) single-nucleotide polymorphism and also the
correlation between stx2c carriage and genotypes 5 and 6 (de-
fined by insertion sites of other phages). Both of these corre-
lations are inconsistent with highly dynamic phage movement.
Second, we observed stability of cluster 1 and cluster 3 geno-
types among multiple isolates from several farms over multiple
years, which is inconsistent with the possibility that the phage
exposure in bovine environments results in rapid conversion to
“bovine” phage insertion site genotypes. More generally,
pulsed-field gel electrophoresis profiles, which would be ex-
pected to be highly sensitive to genetic changes at the scale of
bacteriophage insertions or excisions, have been empirically
observed to be well conserved among epidemiologically related
isolates of -glucuronidase-negative E. coli O157:H7 (1, 2, 32).
In contrast, in a different lineage of enterohemorrhagic E. coli
O157, sorbitol-fermenting E. coli O157:NM, the pulsed-field
gel electrophoresis patterns are less stable because of rapid
bacteriophage recombination activity (3, 19). It will be impor-
tant to specifically evaluate the stability of diverse Stx-encoding
bacteriophage insertion site genotypes in future studies.
The heterogeneity of bovine E. coli O157:H7 genotypes re-
ported here has implications for pathophysiology, evolutionary
genetics, and food safety. First, two key virulence factors, the
production of Stx and the ability to colonize the colonic surface
through the functions of LEE-encoded products, are believed
to be central to the pathophysiology of E. coli O157:H7-in-
duced disease. Most isolates, including those with genotypes
underrepresented among clinical isolates, nevertheless pos-
sessed both of these factors. Thus, it is possible either that
these isolates differ in the level of expression of Stx or LEE-
encoded products (as was demonstrated here with reduced Stx
production for genotype 5 compared to the cluster 3 genotype)
or that they lack another, currently unrecognized virulence
factor(s). Therefore, identification of the genetic basis under-
lying the nonrandom distribution of these genotypes could
expand our understanding of the pathophysiology of this im-
portant human pathogen. This could apply even more broadly
to Stx-producing E. coli isolates belonging to other serotypes.
Of the more than 250 serotypes of Stx-producing E. coli de-
tected in the bovine reservoir, fewer than 100 have been asso-
ciated with human illnesses (9, 10), and only a few serotypes
cause most human infections. It is possible that some of the
same genetic differences that account for the distribution of
nonclinical genotypes of E. coli O157:H7 also account for the
distribution of nonclinical Stx-producing E. coli serotypes.
Second, these findings shed additional light on the recent
evolution of E. coli O157:H7. At any given time, the vast
majority of E. coli O157:H7 isolates reside in the animal res-
ervoirs and not in humans, but studies of the evolution of E.
coli O157:H7 have focused on clinical isolates. Shaikh and Tarr
proposed an evolutionary lineage in which evolving E. coli
O157:H7 sequentially acquired Stx-encoding bacteriophages in
specific chromosomal locations (27). It is possible that some of
the genotypes identified here represent additional steps in this
lineage. For example, genotype 9 has the fimH sequence, yehV
and wrbA occupancy, and Stx profile expected of an immediate
ancestor of the cluster 1 genotype. However, most of the new
genotypes reported here appear to represent evolutionary off-
shoots within the -glucuronidase-negative E. coli O157:H7
clade. For example, genotype 8 could represent a single exci-
sion of the Stx2-encoding bacteriophages from a cluster 3 E.
coli O157:H7 strain. Additional genetic information is required
in order to place such offshoots into a plausible phylogeny.
Third, these findings should prompt additional epidemio-
logic studies of E. coli O157:H7 in the animal reservoir, in the
environment, and in contaminated food products in order to
determine whether the cluster 1 to 3 genotypes differ from
other genotypes in terms of the distribution among potential
sources of human infection. It is also possible that regulatory
attention should be focused more on the subset of E. coli
O157:H7 genotypes overrepresented among clinical isolates.
Kim et al. (14) first reported differential distribution of E.
coli O157:H7 lineages among isolates from cattle and humans
that was consistent with differences in human infectivity or
pathogenicity in certain isolates. These investigators used oc-
tamer-based scanning to identify two E. coli O157:H7 lineages,
one of which more frequently contained human clinical isolates
and the other of which more frequently contained bovine iso-
lates. Interestingly, much of the variation seen with octamer-
based scanning was associated with bacteriophage-related se-
quences. The results of subsequent investigations of a larger
and more diverse panel of isolates using simplified techniques
supported the hypothesis that there is nonrandom distribution
of these lineages in cattle and human hosts but that the degree
is considerably lower than that originally proposed (15, 35).
The correlation, if any, between the lineages reported in these
previous studies and the genotypes reported here is not known.
Roe et al. (26) reported differences between human clinical
and bovine isolates in the proportion of cells expressing LEE-
encoded EspA filaments, with human isolates having higher
proportions of filament-expressing cells. The possibility that
EspA expression varies between genotypes found in both bo-
vine and clinical isolates (cluster 1 to 3 genotypes and genotype
4) and genotypes found only in bovine isolates has not been
evaluated to date. However, data for in vitro cytoadherence
and actin accumulation (Fig. 1 and Table 4) do not indicate
that there are large intrinsic differences between these geno-
type groups in terms of LEE expression.
Our Stx-encoding bacteriophage insertion site data correlate
with two other markers previously reported to be nonrandomly
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distributed among E. coli O157:H7 strains from cattle and
humans. The stx2-Q933W antiterminator gene junction was
more common in human isolates than in cattle isolates (17).
The D78E tir polymorphism was more common in cattle iso-
lates than in human isolates (Bono et al., Abstr. 104th Gen.
Meet. Am. Soc. Microbiol.). Here, we show that these markers
are nonrandomly distributed among E. coli O157:H7 geno-
types in our set of cattle isolates and that their distribution is
consistent with the frequency at which these genotypes occur in
human disease isolates. Q933W occurred in all but one bovine
cluster 1 to 3 genotype or genotype 4 isolate but significantly
less frequently in isolates with other genotypes. The tir poly-
morphism sp-1 was significantly less common in bovine cluster
1 to 3 genotype or genotype 4 isolates than in isolates with
other genotypes. These observations suggest that genotypes
with diverse potentials for human disease distinguishable by
their Stx-encoding bacteriophage insertion site genotypes co-
exist in bovine populations.
In summary, the diversity within the non-sorbitol-ferment-
ing, -glucuronidase-negative E. coli O157:H7 clade is under-
estimated by evaluation of clinical isolates alone. This diversity
is more fully demonstrated by animal (bovine) isolates, and it
appears that no single linear phylogeny could encompass this
diversity. Studies of broader panels of isolates from cattle and
perhaps other animal species are necessary to confirm the
distribution of E. coli O157:H7 Stx-encoding bacteriophage
insertion site genotypes in cattle and to understand the basis
for their different occurrence in clinical isolates.
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